Registry of Lobbyists
| Organization: | Innovative Medicines Canada/Médicaments novateurs Canada |
| Associated registration: | 782797-371-62 |
| Communication date: | 2018-05-15 |
| Posted date: | 2018-06-12 |
| Designated Public Office Holders who participated in the communication: |
David McFarlane,
Director of Policy
Innovation, Science and Economic Development Canada (ISED) Hilary Travis, Policy Advisor Innovation, Science and Economic Development Canada (ISED) |
| Subject Matter of the communication: | Health, Industry |
| Responsible Officer who filed this communication report: | Pamela Fralick |
| As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed. | |